FDA’s one-day inspection assessment pilot: prepare for focused questions and a wider review
2026 inspection update · Source reviewed October 29, 2026.
FDA announced a pilot for one-day inspectional assessments on May 6, 2026. The announcement described shorter, focused screening assessments that complement standard inspections, with risk-based facility selection. FDA said the pilot was planned through fiscal year 2026 and investigators could expand the scope or duration when warranted. This article reviews that announcement; it does not establish the pilot’s status after fiscal year 2026.
Prepare for focus without assuming a fixed endpoint
Our suggested readiness drill starts with a narrow question and tests whether the team can retrieve the supporting evidence. It then adds a related question that requires another department. The aim is a coherent explanation across handoffs, not a promise that an inspection will be short.
- Confirm who receives the investigator and coordinates requests.
- Connect the facility’s current operations with its product and quality records.
- Practice a record request that moves from production to laboratory to quality review.
- Keep an accurate list of outstanding requests and unresolved evidence.
- Rehearse escalation if additional expertise or a broader review becomes necessary.
Choose a practical next step
A virtual session can test a document handoff. An onsite mock inspection can explore facility flow and interviews. Select the scope around your product, operations, and readiness gaps.
Request virtual or onsite readiness support
Mock inspections and gap assessments · Preparation exercises · August conference interest — dates and format TBD
Official source
FDA: FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight — May 6, 2026.